Graham CS - Search Results

1

Treatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporin-resistant Enterobacter species.

Schwaber MJ, Graham CS, Sands BE, Gold HS, Carmeli Y. Schwaber MJ, et al. Among authors: graham cs. Antimicrob Agents Chemother. 2003 Jun;47(6):1882-6. doi: 10.1128/AAC.47.6.1882-1886.2003. Antimicrob Agents Chemother. 2003. PMID: 12760862 Free PMC article.

2

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis.

Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, Koziel MJ. Graham CS, et al. Clin Infect Dis. 2001 Aug 15;33(4):562-9. doi: 10.1086/321909. Epub 2001 Jul 6. Clin Infect Dis. 2001. PMID: 11462196

3

Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV.

Graham CS, Curry M, He Q, Afdhal N, Nunes D, Fleming C, Horsburgh R, Craven D, Sherman KE, Koziel MJ. Graham CS, et al. Hepatology. 2004 Jul;40(1):125-32. doi: 10.1002/hep.20258. Hepatology. 2004. PMID: 15239095

4

Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection.

Graham CS, Wells A, Liu T, Sherman KE, Peters M, Chung RT, Bhan AK, Andersen J, Koziel MJ; ACTG 5071 Study Team. Graham CS, et al. AIDS. 2005 May 20;19(8):767-73. doi: 10.1097/01.aids.0000168970.80551.3d. AIDS. 2005. PMID: 15867490 Free PMC article. Clinical Trial.

5

Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort Study.

Clements KM, Clark RE, Lavitas P, Kunte P, Graham CS, O'Connell E, Lenz K, Jeffrey P. Clements KM, et al. Among authors: graham cs. J Manag Care Spec Pharm. 2016 Jun;22(6):714-722b. doi: 10.18553/jmcp.2016.22.6.714. J Manag Care Spec Pharm. 2016. PMID: 27231798 Free PMC article.

6

Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.

Graham CS, Brodie SB, Weller PF. Graham CS, et al. Clin Infect Dis. 2001 Jul 1;33(1):1-5. doi: 10.1086/320870. Epub 2001 May 23. Clin Infect Dis. 2001. PMID: 11389487

7

Health-related quality of life of patients with HIV disease: impact of hepatitis C coinfection.

Fleming CA, Christiansen D, Nunes D, Heeren T, Thornton D, Horsburgh CR Jr, Koziel MJ, Graham C, Craven DE. Fleming CA, et al. Clin Infect Dis. 2004 Feb 15;38(4):572-8. doi: 10.1086/381263. Epub 2004 Jan 26. Clin Infect Dis. 2004. PMID: 14765352

8

Why should hepatitis C affect immune reconstitution in HIV-1-infected patients?

Graham CS, Koziel MJ. Graham CS, et al. Lancet. 2000 Dec 2;356(9245):1865-6. doi: 10.1016/S0140-6736(00)03251-7. Lancet. 2000. PMID: 11130376 No abstract available.

9

Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection.

Graham CS, Wells A, Liu T, Sherman KE, Peters M, Chung RT, Bhan AK, Andersen J, Koziel MJ; ACTG 5071 Study Team. Graham CS, et al. AIDS. 2006 Feb 14;20(3):345-51. doi: 10.1097/01.aids.0000206500.16783.2e. AIDS. 2006. PMID: 16439867 Free PMC article. Clinical Trial.

10

Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States.

Rosenthal ES, Graham CS. Rosenthal ES, et al. Among authors: graham cs. Infect Agent Cancer. 2016 May 16;11:24. doi: 10.1186/s13027-016-0071-z. eCollection 2016. Infect Agent Cancer. 2016. PMID: 27186235 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters